UroGen Pharma Appoints Peter P. Pfreundschuh as Chief Financial Officer

Go back to UroGen Pharma Appoints Peter P. Pfreundschuh as Chief Financial Officer
(NASDAQ: URGN) Delayed: 42.24 --0 (-0%)
Previous Close $42.24    52 Week High
Open $42.24    52 Week Low
Day High $42.24    P/E N/A 
Day Low $42.24    EPS
Volume 24       

(NASDAQ: URGN) Delayed: 42.24 --0 (-0%)
Previous Close $42.24    52 Week High
Open $42.24    52 Week Low
Day High $42.24    P/E N/A 
Day Low $42.24    EPS
Volume 24